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Traditional plants from Asteraceae family as
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Traditional plants have been used in the treatment of disease and pain due to their beneficial properties
such as antioxidant, antiinflammation, analgesic, and antibiotic activities. The Asteraceae family is one of
the most common groups of plants used in folk medicine. The species Achillea millefolium, Arnica
montana, Bellis perennis, Calendula officinalis, Chamaemelum nobile, Eupatorium cannabinum,
Helichrysum stoechas, and Taraxacum officinale have been used in different remedies in Northwest
Spain. Besides health benefits, some of them like C. nobile and H. stoechas are already employed in
cooking and culinary uses, including cocktails, desserts, and savory dishes. This study aimed to review the
current information on nutritive and beneficial properties and bioactive compounds of these plants,
which are not mainly used as foods but are possible candidates for this purpose. The report highlights
their current uses and suitability for the development of new functional food industrial applications.
Phenolic compounds, essential oils, and sesquiterpene lactones are some of the most important com-
pounds, being related to different bioactivities. Hence, they could be interesting for the development of
new functional foods.
1. Introduction
Plants have been around human beings since ancient times.
Throughout history, some plants have been chosen as food;
some specific plants that were orally consumed ameliorated or
had punctual benefits for the treatment or prevention of par-
ticular diseases, have been selected and described as “tra-
ditional plants” (TP).1 These plants have been traditionally
applied for the cure of some disorders, but they have also
stood out as raw materials for the recovery of specific mole-
cules, also known as bioactive compounds, and have shown
the scientific evidences of promoting health beneficial
properties.2,3 In this sense, TP can be used for two different
purposes. On one hand, there is the traditional part associated
with the preservation of ancient knowledge and their use for
therapeutic purposes under different consumption formu-
lations (decoctions, infusions, ointment, etc.), which have
been maintained over time. On the other hand, TP can be
used in cooking and culinary applications, and they can be
revalorized for recovering bioactive compounds intended for
the food industry.1
TP are being increasingly consumed, according to two dia-
metrically opposite realities. On one side, those countries or
regions with a lower socioeconomic status choose to use med-
icinal plants instead of chemically synthesized drugs for
different reasons. In some cases, these drugs are expensive
and hardly accessible for these populations, while medicinal
plants are natural, abundant, available, and a low-cost remedy.
In addition, in these cases, the population can carry out its
own collection and administration of plants as a legal
practice.2,4 The other reality—closer to Western and more
developed populations—refers to the new trend of preference
for consuming natural foods over processed ones. In this case,
the choice of these products is usually related to the adverse
effects associated with food, supplements, and additives of
artificial origin.5,6 The current risk perception of consumers
regarding the food chain is influenced by food contamination
accidents, the excessive use of pesticides, the introduction of
genetically modified organisms, and the use of artificial ingre-
dients. Moreover, their opinion is also motivated by an
increase in cardiovascular diseases, where the lifestyle and
food habits play a crucial role, as well as other disorders, such
as allergies or intolerances also related to different food prac-
tices.7 Therefore, there is a moving trend toward natural
products.†These authors contributed equally to this work.
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TP and aromatic plants have been widely used as a raw
ingredient in human diet. Because of their demonstrable ben-
eficial properties, they are used as food supplements, sold as
capsules, powders, extracts or fresh/dried plants and con-
sumed in salads, decoctions, and infusions.1,5 Likewise, they
have been included in animal diets as they entail a safe
alternative for replacing or diminishing synthetic ingredients
while enhancing the immune status of animals.8,9 Apart from
their primary use as natural medicines, TP are being proposed
as a source of plant extracts and bioactive compounds with
uses in the functional food industry.10–12 In this regard,
several studies have been conducted to evaluate the biological
properties of TP, which range from antioxidants13,14 to antiin-
flammatory products15 such as antimicrobial16,17 or antitu-
mor18 products. In the food industry, one of the main appli-
cations of TP is as a preservative due to their antioxidant and
antimicrobial properties, which prevent oxidation, avoid
microbial growth, and preserve the organoleptic characteristics
of diverse products (such as meat, seafood, milk and dairy
products19–22). New applications such as the incorporation of
these natural compounds into food active packaging are also
gaining importance.23 Many of the described bioactive pro-
perties are due to the presence of phenolic compounds (PC).
These compounds are the secondary metabolites of plants,
which are principally well known for their strong antioxidant
capacity, among other advantages.24 In particular, these mole-
cules have been highlighted as an alternative to synthetic anti-
oxidants such as butylated hydroxytoluene (BHT).13,25 On the
other hand, several studies have included TP extracts and bio-
active compounds in different food matrixes to develop
enriched products.26–30
TP can be found along with many families and in different
locations. Northwest Spain possesses varied flora and a high
number of species can be used as functional ingredients.1
Among other families, Asteraceae species are promising candi-
dates due to their bioactive compounds and associated ben-
eficial properties.18,31–34 This family of cosmopolitan distri-
bution and easiness of adaptability includes 8–10% of the
known angiosperms and accounts for 24 000–25 000 species
and 1600–1700 genera.35,36 These plants are characterized by
their great adaptability to different habitats or environmental
conditions and their diversity of habits. They can be found in
all continents, except Antarctica.36 In fact, some plants of this
family have already been used in the food industry for develop-
ing functional foods.37,38 With regard to its chemical compo-
sition, Asteraceae is the family where a group of polyacetylenes
is the most prevalent, which is an organic polymer present in
the roots (R) of plants.39 Asteraceae family is also rich in ses-
quiterpenes, a group of highly diverse 15-carbon terpenes,
which are the major elements of essential oils (EO) and exert
different biological activities, entailing medicinal and aromatic
potential for the food industry.40 Interest on EO from this and
other families has been increasing in the last few years on the
basis of their broad spectrum of bioactive components and
associated activities.41 For instance, sesquiterpene lactones
(SL) identified in the Asteraceae family have exhibited anti-
microbial and antiinflammatory properties, among others.42
Furthermore, plants usually possess a wide collection of free-
radical-scavenging molecules, highlighting the potential of PC
as well as other molecules such as nitrogen compounds, vita-
mins, or terpenoids (Te).43 Several species from the Asteraceae
family are known for their Te (SL) and PC (flavonoids (F) and
phenolic acids (PA)) contents—both responsible for their anti-
oxidant activity.43,44
In particular, this review has focused on the following
species: Achillea millefolium, Arnica montana, Bellis perennis,
Calendula officinalis, Chamaemelum nobile, Eupatorium cannabi-
num, Helichrysum stoechas, and Taraxacum officinale (Fig. 1).
These eight plants can be found in northwest Spain and the
current knowledge of their beneficial properties depends on
the target species. For instance, yarrow (A. millefolium), dande-
lion (T. officinale), and calendula (C. officinalis) have been com-
prehensively studied. Te (SL and pentacyclic triterpenes (Tt)),
F, and PA—apart from carotenoids (Ca) in the case of
C. officinalis—have been reported as the major components of
these plants.45–47 In the case of A. montana or B. perennis, their
main bioactive compounds have been demonstrated to be SL
in the case of A. montana (responsible for its antiinflammatory
effects),48 and Tt saponins (Sa), F, and aromatic and acyclic
alcohol glycosides in the case of B. perennis.49 Perhaps, the
remaining species, namely, C. nobile, E. cannabinum, and
H. stoechas, are less frequently studied in terms of their bio-
logical properties, although there are some research articles
from the 90s and the beneficial properties of C. nobile on
digestive health are generally well known. Their biological
(mainly, antiinflammatory,50 antitumor,51 and antimicrobial52)
properties are a consequence of the action of SL and F, as well
as tannins and EO.52 Considering all this information and due
to the knowledge gap in some of the abovementioned species,
this review is aimed at compiling currently available infor-
mation of the nutritional and biological properties of this
plant and also their current uses in the industry. In this way, it
is intended to scientifically justify the traditional use of these
plants and highlight the bioactivities and compounds that
could be of interest to diversify their food industry appli-
cations, thereby revalorizing them (Fig. 2).
2. Plants from Asteraceae family
candidates for functional food
applications
In this section, scientific studies evaluating the beneficial pro-
perties of the selected plants will be explained. In addition, in
Table 1, the traditional form of application (oral administration
being the most common form) and the diseases treated with
these plants are summarized in order to highlight their possible
use as food plants. Table 2 lists numerous studies of the bioac-
tivities and bioactive compounds that are considered to play a
fundamental role in them. The compiled information may be of
reference for its potential application in functional foods.
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This plant—traditionally known as yarrow—grows in Asia,
Africa, Europe, and America, and it is very common in folk
medicine.53 Stems, leaves (L), and special flowers (FL) are used
to prepare an infusion or decoction for the treatment of dia-
betes and gastrointestinal, spasmodic, cardiovascular, respirat-
ory, and hepatobiliary disorders, and they have been used as a
Fig. 2 TP of the Asteraceae family present numerous bioactive compounds, responsible for their biological properties and their use in folk medi-
cine. These plants are currently used in different products, but the understanding of their mechanisms of action and compounds involved in the bio-
active properties could prompt the development of new industrial applications.
Fig. 1 Identification and characteristics of the different species studied in this review.178,179
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hemostatic and externally applied to heal wound and
inflammation.54,55 The main phytochemical compounds that
have been isolated from A. millefolium are EO, PC (including
PA and F, e.g., apigenin, rutin, or lutein), fatty acids, amino
acids, tannins, and Te.53,54 Different biological properties
have been attributed to this plant, such as antioxidant, anti-
inflammatory, analgesic, hemostatic, antitumor, antidiabetic,
antimicrobial, spasmolytic, liver protector, anti-asthmatic,
and anxiolytic,54,56–58 which could be of interest for food
enrichment.
Starting with the antioxidant activity, numerous studies
have evaluated the antioxidant activity of different extracts, for-
mulations, and compounds of A. millefolium. For example, the
methanolic extract, infusion, and decoction of wild and com-
mercial yarrow were compared in terms of their antioxidant
activity in vitro, using 2,2-diphenyl-1-picrylhydrazyl (DPPH)
assay, ferric reducing/antioxidant power assay (FRAP),
β-carotene/linoleate assay (inhibition of β-carotene bleaching),
and the inhibition of lipid peroxidation in porcine brain,
using thiobarbituric-acid-reactive substances (commonly
known as the TBARS assay). The results showed that commer-
cial yarrow presented a higher antioxidant activity compared
with the wild samples. Decoctions presented greater DPPH
scavenging activity (EC50: 0.20 mg mL
−1), inhibition of
β-carotene bleaching (EC50: 0.22 mg mL−1), and TBARS inhi-
bition (EC50: 0.08 mg mL
−1), whereas infusions showed the
greatest reducing power (EC50: 0.13 mg mL
−1) using a FRAP
test.59 A recent study evaluated the radical scavenging activity
of different extracts of A. millefolium by DPPH and 2,2′-azino-
bis(3-ethylbenzothiazoline-6-sulfonic) acid (ABTS) scavenging
assays. According to the results, the water extract exhibited the
greatest antioxidant activity and a correlation between the PC
content and results was observed.60 EO from this plant have
been also found to present antioxidant properties and could
scavenge DPPH radicals.61 The antioxidant effects of this plant
have been also corroborated using in vivo models, increasing
the antioxidant defenses and reducing lipid peroxidation in
different models, such as acetic-acid-induced gastric ulcers62
and cyclophosphamide-63 and nicotine-induced toxicity in
rats.64
Regarding antiinflammatory properties, EO seem to be
responsible for this activity. For example, EO of yarrow signifi-
cantly repressed the production of nitric oxide (NO) in macro-
phages stimulated by lipopolysaccharide (LPS).65 A later study
reported that different A. millefolium fractions reduced the
production of tumor necrosis factor alpha (TNF-α), interleu-
kin 8 (IL8), and IL6 in LPS-activated macrophages. In particu-
lar, the chemical composition of the most active fractions
revealed a higher content in the EO components.66
Antiinflammatory effects have been also observed in vivo.
Traditional oil yarrow extracts were used in the treatment of
the irritated skin of volunteers. The results showed that the
extracts improved the erythema index, as well as skin capaci-
tance and its pH, demonstrating significant antiinflammatory
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Abbreviations: AP, aerial parts; R, roots; FL, flowers; L, leaves.
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Table 2 Studies on A. millefolium, A. montana, B. perennis, C. officinalis, C. nobile, E. cannabinum, H. stoechas, and T. officinale bioactivities and
their related compounds
Effects Effects observed Compounds Ref.
Achillea millefolium
Antioxidant In vitro: Positive results in DPPH, ABTS, FRAP, β-carotene bleaching, TBARS assays PC, EO 28–34
In vivo: Increase antioxidant defense, reduction of lipid peroxidation
Anti-
inflammatory
Inhibition of pro-inflammatory cytokines in LPS-stimulated macrophages EO 35–37
Antitumor Cell cycle arrest & apoptosis of HCT-15, NCI-H460, HeLa, K562, MiaPaca-2, MCF, HepG2 cells PC, F 28, 29 and
38–40
Antimicrobial Inhibition of bacteria S. aureus, S. typhimurium, S. mutans, B. cereus, E. coli, P. aeruginosa, P.
mirabilis and fungi C. albicans, B. cinerea, R. stolonifera, V. dahliae, A. niger and C. gloeosporioides
EO 41 and 42
Other activities Relax the airways of rat trachea. Anxiolytic effects on mice. Improvement of skin hydration and
appearance
NA 1, 43 and 44
Arnica montana
Antioxidant In vitro: Positive results in DPPH, ABTS, inhibition of linoleic acid peroxidation, FRAP and
chelating power. Inhibition of lipoxygenase and xanthine oxidase. Reduction of oxidative stress in
mouse fibroblast L929 cells. In vivo: Antioxidant defense, reduction of lipid and protein oxidative
damage
PC, F, SL, Ps 4 and 45–48
Anti-
inflammatory
In vitro and In vivo: Inhibition of NF-κB pathway, reduction of pro-inflammatory cytokines SL, F, PC, PS 45–49
Antitumor Cytotoxic effect against anaplastic astrocytoma and glioblastoma multiform cells EO 50
Bellis perennis
Antioxidant Positive results in DPPH, ABTS, FRAP, ORAC and β-carotene bleaching assays PC, F 7 and 51–53
Anti-
inflammatory
Inhibition of NO production in LPS-stimulated RAW 264.7 cells PC, Te 52 and 53
Antitumor Inhibition of HL-60, MCF-7, HepG2/C3A, A-549 and DLD-1 cancer lines Sa, NA 53 and 54
Antibacterial Inhibitory activity against S. pyogenes, S. aureus and S. epidermis NA 53
Other properties Accelerated wound healing, hematoprotective and nephroprotective activities, hypolipidemic
effects
NA 52, 55 and
56
Calendula officinalis
Antioxidant In vitro: Positive results in DPPH, ABTS, FRAP, chelating power, β-carotene bleaching, TBARS,
scavenging of NO, hydroxyl radical and lipid peroxyl radicals.
PC, F 9–12, 57
and 58
In vivo: Increase antioxidant defense, reduction of lipid peroxidation
Anti-
inflammatory
In vitro: Inhibition of TNF-α in LPS-stimulated macrophages F, Tt 59–61
In vivo: Inhibition of pro-inflammatory cytokines and the expression of Cox-2. Reduction
inflammation of different disease-model animals
Wound healing Activation of NF-κB pathway, stimulation of re-epithelization Tt, Ca, EO 13
Antitumor Cytotoxic effects against HeLa, HepG2, K562, colon, melanoma and leukemia cancer cells Tt, F 9, 59 and 62
Antimicrobial Inhibitory effects on E. coli, P. aeruginosa, B. subtilis, S. aureus, L. monocytogenes, S. typhimurium,
C. albicans, C. parapsilosis and A. niger. Inhibition of promastigotes and amastigotes of L. major
NA 12, 63 and
64
Chamaemelum nobile
Antioxidant Positive results in DPPH, FRAP, inhibition of lipid peroxidation PC, OA, EO 16 and 65
Anti-
inflammatory
In vitro: Inhibition of inflammatory pathways PC, Ps 15, 66 and
67In vivo: Inhibitory and analgesic effects on paw edema
Antitumor Cytotoxic effects MCF-7, NCI-H460, HCT-15, HeLa, HepG2, K562, SKMEL-3 cancer cell lines PC 14 and 16
Antimicrobial In vitro: Inhibitory activity against S. aureus, Bacillus sp., P. aeruginosa and E. coli. PC, EO 65, 68 and
69In vivo: Inhibition of P. aeruginosa in wounds
Eupatorium cannabinum
Antioxidant Positive results in DPPH assay and electrochemical potential sweep technique. PC, EO 18 and 19
Anti-
inflammatory
In vitro: Modulation of pro-inflammatory factors SL 21 and 70
In vivo: Reduction of pro-inflammatory cytokines in mice models
Antitumor Cytotoxic effects against Jurkat, CCRF-CEM, HL-60, BT-20, HepG2, Caco-2 cell lines NA 21, 70 and
71
Antimicrobial Inhibition of E. coli, B. cereus, S. aureus, E. faecalis, S. faecalis, B. subtilis, P. mirabilis, E. coli, S.
typhi, P. aeruginosa and C. albicans, B. theobromae, C. gloeosporioides
EO 72–74
Helichrysum stoechas




Inhibition of NF-κB and TNF-α NA 78
Antitumor Inhibit the proliferation of HeLa cells NA 23
Antimicrobial Inhibitory effects against E. coli, P. aeruginosa, P. mirabilis, K. pneumoniae, A. baumannii, E.
faecalis, S. aureus, M. phlei, C. albicans and C. parapsilosis
NA 75 and 79
Neuroprotective Inhibition of enzymes related to central nervous system and neurotransmitter metabolism NA 23 and 75
Taraxacum officinale
Antioxidant In vitro: Scavenging activity against DPPH, OH− and O2
−, inhibition of lipid peroxidation.






In vivo: Increase O2
− scavenging activity, reduced lipid peroxidation and protein oxidative damage
Anti-
inflammatory
In vitro: Inhibition of NF-κB inflammatory pathway, reduction of pro-inflammatory cytokines PC, Ps 82–85
In vivo: Inhibition of pro-inflammatory compounds and genes related with inflammation
Antitumor Induces apoptosis in HepG2, MCF7 and HCT116 cell lines Ps 86 and 87
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properties, thereby justifying the traditional uses of
A. millefolium.67 It is also beneficial as a therapy in the case
of patients with multiple sclerosis. For its evaluation, a
placebo-controlled clinical trial was carried out over a year
with different amounts of A. millefolium extract (0.2 and 0.5 g
day−1), which significantly reduced the relapse rate and pre-
vented progression in multiple sclerosis associated with
relieving inflammation. Thus, this plant may become comp-
lementary treatment for multiple sclerosis68 and also toward
the relief of pain from diseases such as primary dysmenor-
rhea; this has been corroborated in a trial carried out with 50
women in western Iran.69
This plant has also been reported for presenting antitumor
properties, inducing cell-lifecycle arrest, and apoptosis of
different cancer lines. PC have been reported to play an impor-
tant role in these cases. For example, casticin—F isolated from
yarrow—induced the apoptosis and cell-lifecycle arrest at the
G2/M stage for different cancer cell lines.70 A later study
reported that the hydroethanolic extracts of yarrow displayed
inhibitory effects on small-cell lung cancer (NCI-H460) and
colorectal adenocarcinoma (HCT-15) cell lines (with GI50
values of 187.3 and 70.8 μg mL−1, respectively) by altering the
cell lifecycle and induction of apoptosis. The authors
suggested that PC could be the bioactive compounds respon-
sible for the antitumor activity.71 A study by Abou Baker
(2020), as mentioned earlier, also determined the cytotoxicity
of different extracts against several cancer cell lines. Ethyl
acetate extracts showed the greatest cytotoxic effects against
cervical carcinoma (HeLa) and chronic myelogenous leukemia
(K562) cancer cells, with IC50 values of 0.58 and 0.73 μg mL−1,
respectively. Similar to the previous example, the antitumor
activity may be related to the high amount of PC present in the
extracts.60 Other cancer cell lines that have been inhibited by
A. millefolium include breast adenocarcinoma (MCF-7), hepato-
cellular carcinoma (HepG2), and pancreatic human tumor cell
line (MiaPaca-2).59,72
Several studies have demonstrated the antibacterial and
antifungal activities of A. millefolium. For instance, EO
extracted from this plant showed in vitro antibacterial activity
against different bacteria and fungi. Regarding bacteria,
Staphylococcus aureus, Salmonella typhimurium (minimal
inhibitory concentration (MIC) of 125 μg mL−1), and
Streptococcus mutans (MIC of 250 μg mL−1) were the most
affected, while Candida albicans strains were the most suscep-
tible fungi species (MIC: 125–250 μg mL−1).45 In the study by
Kazemi (2015), Bacillus cereus, Escherichia coli, Pseudomonas
aeruginosa, and Proteus mirabilis were the most affected bac-
terial species by the EO (MIC: 2.5 μg mL−1). With regard to the
C. albicans and Aspergillus fumigatus fungi, the MIC values
were 1 and 2 μg mL−1, respectively.65 Yarrow EO have been
reported to inhibit other fungi, namely, Botrytis cinerea,
Rhizopus stolonifera, Verticillium dahliae, A. niger, and
Colletotrichum gloeosporioides.73 In an in vivo study involving
cancer patients, a trial was performed using A. millefolium dis-
tillate as a mouthwash to reduce oral mucositis. This solution
could be given to all patients during chemotherapy and had
no side-effects.74
Other activities have been attributed to A. millefolium, such
as anti-asthmatic and anxiolytic. It facilitated wound healing
in a study conducted with first-time pregnant women with epi-
siotomy wounds75 Organic and hydroalcoholic extracts have
demonstrated the relaxation of airways in the rings of isolated
rat trachea in a dose-dependent manner. Hexanic extracts were
the most efficient ones, which acted through the blockage of
calcium channels and NO release.54 Regarding anxiolytic
activity, the oral administration of yarrow hydroalcoholic
extracts produced anxiolytic effects in mice, with a behavior
similar of that caused by diazepam.57
2.2. A. montana
Commonly known as arnica, A. montana is native to the
central mountains in Europe. R and FL extracts have been
externally applied as tinctures or ointments to alleviate
different problems such as bruises, sprains, rheumatic pain,
or skin inflammation; it is even used in veterinary treatment
for joint inflammations as well as for cleaning and treating
wounds in the skin.76,77 Among the phytochemical com-
pounds present in this plant, PA, F, EO, Te, and SL could be
highlighted. Some studies have attributed arnica to have anti-
oxidant and antiinflammatory properties.77,78 However,
despite being a plant widely used in traditional medicine
and currently employed in commercial products, there are a
few studies that support their properties, compared with
other plants of the Asteraceae family. Other less studied
bioactivities of A. montana include anticancer, antimicrobial,
immunomodulation, hepatoprotective, analgesic, or antic-
ough properties79,80
The antioxidant properties of this plant have been briefly
studied, but it has been described that F and SL are the
primary causes of this action.81 The antioxidant activity of tinc-
Table 2 (Contd.)
Effects Effects observed Compounds Ref.
Antimicrobial Inhibition of S. aureus, E. coli, K. pneumonia, P. mirabilis, Micrococcus luteus, Vibrio cholera, P.
aeruginosa, B. cereus, Shigella sonnei, C. albicans, C. neoformans, A. niger and B. cinerea. Inhibition
of influenza and hepatitis C viruses
NA 27 and
88–90
Other properties Anticoagulant, α-glucosidase inhibitory activity, immunostimulant or neuroprotective NA 80 and
91–94
Compounds: NA, not analyzed; PC, phenolic compounds; F, flavonoids; Ps, polysaccharides; Te, terpenoids; Tt, triterpenoids; EO, essential oil; SL:
sesquiterpene lactones; Sa: saponins; Ca: carotenoids; OA, organic acids; PIEs, 4-hydroxyphenylacetate inositol esters; HA, hydroxycinnamic acids.
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tures from different parts (FL, herb, and rhizome) of
A. montana was assessed by DPPH assay, inhibition of linoleic
acid peroxidation, FRAP, and chelating power assays. Except
for the case of linoleic acid peroxidation, a correlation was
observed between the antioxidant activity with the PC content
of each part of the plant. In addition, tinctures displayed high
in vitro inhibitory activity in a dose-dependent manner against
lipoxygenase and xanthine oxidase—two enzymes that produce
reactive oxygen species (ROS).81 The ability to scavenge free
radicals of arnica PC and polysaccharides (Ps)-rich extracts has
been assessed by the DPPH assay. The results showed that the
inhibition of DPPH was augmented in a dose-dependent
manner, the PC-rich extract being the most efficient (IC50:
0.66 mg mL−1). In addition, the extracts and also their liposo-
mal formulations significantly reduced the oxidative stress
caused by H2O2 in mouse fibroblast L929 cell culture.
82 The
EO of A. montana have also demonstrated antioxidant pro-
perties. DPPH and ABTS assays conducted with EO showed
IC50 values of 4.79 and 0.35 mg mL
−1, respectively. The results
of FRAP (IC50: 31.15 mg mL
−1) and phosphomolybdenum
assays (55.69 mg ascorbic acid equivalents per g) also demon-
strated the antioxidant effects of arnica EOs.76 Several in vivo
studies have corroborated the antioxidant properties of arnica.
For example, methanol extracts of arnica FL were orally admi-
nistered to collagen-induced arthritis rats; a significant
improvement in the antioxidant defense was observed in the
joints, spleen, and plasma of the treated animals (reduced
lipid peroxidation and protein oxidative modification) com-
pared with the control.83 Thus, the traditional use of this plant
in treating rheumatoid arthritis is scientifically justified.
Recently, the topical application of an ointment containing
A. montana tincture has been demonstrated to reduce the oxi-
dative stress produced by UVB radiation in mice ears, reducing
carbonylated proteins and lipid peroxidation and improving
antioxidant defense.84
Several studies have evaluated the antiinflammatory pro-
perties, explaining the use of this plant in inflammatory dis-
orders. It has been described that SL and F, in a lesser extent,
act through the inhibition of nuclear factor kappa-light-chain
enhancer of activated B cells (NF-κB), which regulates the tran-
scription of genes involved in inflammation.81,82 Extracts of
A. montana have been reported to exert potent inhibitory
effects against human neutrophil elastase (released by neutro-
phils during inflammation) and NF-κB, attributed to the high
content of SL.85 A further study demonstrated that A. montana
tinctures suppressed the transcription of interstitial collagen-
ase-3 and collagenase-1 in bovine and human articular chon-
drocytes due to the inhibition of the DNA binding of NF-κB
and activator protein-1. In the previous study of Gaspar et al.
(2014), PC and Ps extracts and their liposomal formulations
exerted antiinflammatory effects in H2O2-treated L929 cell
culture by reducing the production of IL-6, IL-8, and TNF-α.82
Antiinflammatory properties have also been evaluated in col-
lagen-induced arthritis rats and UVB-radiated mice. In both
cases, A. montana reduced the levels of proinflammatory cyto-
kines, such as NO, NF-κB, IL-1β, IL-6, and TNF-α.83,84
2.3. B. perennis
Traditionally known as the common daisy, this plant is native
to western, central, and Northern Europe and Middle Asia.
Usually, fresh or dried FL are prepared in infusions, decoc-
tions, and ointments. They have been used to treat bruises,
wounds, cold, gastrointestinal problems, headaches, and skin
disorders, among other diseases; they also have been con-
sumed as diuretic, digestive, or antipyretic.86,87 In their phyto-
chemical composition, PA, F, EO, and Tt Sa are the major com-
ponents described88,89 and the bioactivities reported include
antioxidant, antiinflammatory, anticancer, antimicrobial,
anxiolytic, anti-hyperlipidemic, or wound healing.87,89,90
Several studies have evaluated the antioxidant properties of
B. perennis, which have been attributed to PC. For example, a
significant correlation between PC and F contents and the
results of DPPH and oxygen radical absorbance capacity
(ORAC) assay has been observed in several studies.88,91
Recently, the antioxidant activity of methanolic B. perennis
extracts, among other plants, has been evaluated using DPPH,
ABTS, β-carotene bleaching method, and FRAP assays. In this
case, the IC50 value for DPPH was 168.4 µg mL
−1 while that for
the ABTS assay was 74.69 µg mL−1. Further, β-carotene bleach-
ing afforded an IC50 value of 78.45 µg mL
−1 after 30 min and
85.28 µg mL−1 after 60 min. Finally, for the FRAP assay, the
IC50 value was 557.89 µg mL
−1.90
The antiinflammatory properties of the common daisy have
been evaluated in vitro. B. perennis extracts were evaluated for
studying the inhibition of NO production in murine macro-
phage LPS-stimulated RAW 264.7 cells, where methanolic and
dichloromethane extracts were found to be the most effective.
The authors considered that PC and Te were the bioactive com-
pounds responsible for this action.91 Similarly, in a further
study, methanolic B. perennis extract has demonstrated to
reduce NO production in a dose-dependent manner in LPS-
stimulated RAW 264.7 cells, without affecting the cell viability.
The results of this study showed that the extract reduced NO
production in all the tested concentrations (25–1000 mg
mL−1), causing a 71.7% inhibition at the maximum concen-
tration.90 Although more studies are necessary to elucidate the
mechanisms of action of the antiinflammatory effects of
B. perennis and corroborate their effects using in vivo models,
these studies support its traditional use in various diseases
such as eczema or rheumatism.
To our knowledge, few studies have reported the anticancer
properties of B. perennis. Sa isolated from R exhibited cytotoxic
effects against human promyelocytic leukemia (HL-60) cells. In
another study, methanol extracts presented a modest anti-
cancer effect against MCF-7 and HepG2/C3A cell line. Recently,
it has been shown that daisy extracts had cytotoxic effects
against human lung carcinoma (A-549) and human colon
adenocarcinoma (DLD-1) cell lines.91 This study also evaluated
the antibacterial properties of the extracts. In particular, ethyl
acetate fraction was the one that inhibited the most species of
microorganisms, namely, Streptococcus pyogenes, S. aureus,
S. epidermis, and Enterococcus cloacae, with inhibitory zones of
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12.4, 10.7, 12.9, and 15.9 mm. In general, the extracts were
more effective against Gram-positive species.91
2.4. C. officinalis
This plant, commonly known as pot marigold, is widely dis-
tributed and extends throughout Europe and Asia and can be
also found in Australia.92,93 Traditionally, C. officinalis has pro-
vided different uses, including the elaboration of food, dyes,
cosmetics, and traditional remedies.92,94 FL were used to
prepare aqueous extracts, ointments, and other remedies, par-
ticularly for the treatment of cuts, wounds, dermatological dis-
eases, and skin and oral inflammation, as well as other dis-
orders such as fever, gastritis, jaundice, hypotension, or
rheumatism.47,95,96 Numerous phytochemicals have been
identified in C. officinalis, such as PC (including PA, F, cou-
marins, etc.), Te, and Ca.95,97 Its reported bioactive properties
include antioxidant, antiinflammatory, antibacterial, antiviral,
cytotoxic, and wound healing.97,98
Several studies have demonstrated the antioxidant pro-
perties of C. officinalis. For example, the water extracts of
C. officinalis have shown to scavenge DPPH, hydroxyl radical,
and lipid peroxyl radicals in a dose-dependent manner,
showing a clear correlation with the PC content of the
extract.99 Similarly, infusion and hydromethanolic extracts
were evaluated using DPPH, FRAP, β-carotene bleaching inhi-
bition, and TBARS assays. In all the cases, an antioxidant
effect was observed, which could be attributed to the presence
of F, demonstrating that these compounds are involved in the
antioxidant properties of the plant.95 A recent study revealed
that the lyophilized extracts of marigold inhibited the lipid
peroxidation of in vitro brain tissues of Wistar rats.97
Antioxidant effects have also been reported in vivo. Wistar rats
subjected to burn injury fed with C. officinalis aqueous extracts
showed a better antioxidant defense system than the control
animals. Lipid peroxidation and tissue damage markers were
significantly lower in a dose-dependent manner.98
Hydroalcoholic extracts of C. officinalis also reduced lipid per-
oxidation when administered to male Sprague-Dawley rats.100
In hairless mice irradiated with UVB, a topical formulation
containing C. officinalis effectively protected the skin against
oxidative damage, maintaining reduced glutathione levels
close to nontreated animals and reducing the histological
changes.101
Several studies have evaluated the antiinflammatory pro-
perties of C. officinalis, mainly in vivo. In LPS-stimulated
macrophages, an FL extract significantly reduced the pro-
duction of TNF-α. The same extract also inhibited paw edema
induced by carrageenan, dextran, and formalin in mice when
administered orally. The results showed that C. officinalis
modified the activity of proinflammatory cytokines, such as
IL-1β, IL-6, TNF-α, and interferon-γ, and it also inhibited the
expression of cyclooxygenase-2 (COX-2).102 Different Tt isolated
from the FL of C. officinalis showed strong antiinflammatory
activity on 12-O-tetradecanoylphorbol-13-acetate-induced
inflammation in mice.103 More recently, the hydroalcoholic
extracts of marigold inhibited acute inflammation caused by
ulcerative colitis effects on rats, which could be attributed to
the presence of bioactive compounds in the extracts, including
F and Tt.100
The most popularly reported properties of marigold, i.e.,
the wound healing ones, have been corroborated. Scratch
assays showed that compounds from C. officinalis accelerated
wound closure in NIH-3T3 fibroblasts human dermal fibro-
blast. In human keratinocytes, n-hexane and ethanol extracts
modulated the initial phase of wound healing, which is tem-
poral inflammation necessary in the beginning of the process.
The application of extracts led to the activation of NF-κB and
the production of IL-8. This proinflammatory cytokine is
involved in the proliferation and migration of keratinocytes,
which facilitates re-epithelization and wound healing.
Although the compounds involved in this action were not ana-
lyzed, Tt and Ca are considered to play a role in it.47
Other properties such as antitumor or antimicrobial have
been attributed to this plant. With regard to its antitumor
effects, it has been demonstrated that the hydromethanolic
extracts of C. officinalis exhibited a cytotoxic effect against
HeLa and HepG2 cancer cell lines, while no cytotoxic effect
was observed in nontumor cells.95 Marigold tea showed a
strong cytotoxic effect against different cancer cell lines, par-
ticularly toward Fem-x cells, followed by HeLa and human ery-
throleukemia (K562) cells. The authors considered that
F-glycosides were involved in the observed effects.104 Other
compounds, such as Tt extracted from C. officinalis, displayed
cytotoxic effects against colon, melanoma, and leukemia
cancer cells.103 In the case of antimicrobial activity,
C. officinalis exhibited inhibitory effects against bacterial
species such as E. coli, P. aeruginosa, B. subtilis, S. aureus,
L. monocytogenes, and S. typhimurium, as well as fungi species
such as C. albicans, C. parapsilosis, and A. niger.92,97,105 Finally,
C. officinalis has also shown anti-leishmania effects, inhibiting
the growth of promastigotes and amastigotes of Leishmania
major.105
2.5. C. nobile
C. nobile, called Roman chamomile, is a perennial herb found
in wild and cultivated habitats in Western Europe, North
America, and Northern Africa.106,107 This plant has a long tra-
dition and has been used to alleviate fever and sun stroke,
insomnia, back pain, neuralgia, rheumatism, skin conditions,
indigestion, flatulence, headaches, and gout.108,109 Bioactive
compounds identified in Roman chamomile include Te, F,
and coumarins, as well as other components such as angelic
and tiglic acid esters, anthemic acid, fatty acids, and
choline.107 Numerous biological properties have been docu-
mented for C. nobile, such as antioxidant, antibacterial, anti-
fungal, insecticidal, hypotensive, anti-platelet aggregation,
antiinflammatory, hypoglycemic, cytotoxic, bronchodilator,
and endocrine.110
The antioxidant properties of this plant have been evalu-
ated in several studies. For example, methanolic extract, decoc-
tion, and infusion of C. nobile were evaluated in terms of com-
position and antioxidant potential using DDPH, FRAP, and
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inhibition of lipid peroxidation assays using β-carotene model
system in liposomes and TBARS assay in brain homogenates.
According to the results, methanolic extract presented a better
β-carotene bleaching activity and TBARS inhibition (EC50
values of 443.32 and 82.33 µg mL−1, respectively), while infu-
sion achieved better DPPH scavenging results (EC50: 408.46 µg
mL−1). These results may be related to the high PC content of
methanolic extracts and organic acids (OA) in the case of infu-
sion.106 The EO of C. nobile also present antioxidant pro-
perties, as showed by the DPPH radical scavenging and FRAP
assays (602.73 and 0.13 µg mL−1, respectively).111
As evident in the literature, the antiinflammatory properties
of C. nobile are one of the most studied and described. Six
octulosonic acid derivatives were isolated from FL and were
evaluated using different assays directing nonsteroidal antiin-
flammatory drugs-activated gene-1 (NAG-1), NF-κB, inducible
nitric oxide synthase (iNOS), and ROS. In addition, the effects
on peroxisome proliferator-activated receptors (PPARα and
PPARγ) and liver X receptor, as well as factors related to the
inflammation process and metabolic disorder, were evaluated.
All the compounds increased the NAG-1 activity, which is
involved in the antiinflammatory process, and inhibited ROS
production, reducing the cellular oxidative stress. Some com-
pounds also activated PPARγ and PPARα, resulting in the sup-
pression of the inflammatory process. Considering these
results, these compounds may partially explain the antiinflam-
matory properties of C. nobile.112 Recently, the oral adminis-
tration of EO from Roman chamomile reduced paw inflam-
mation and exerted analgesic effects against thermal pain, cor-
roborating the use of C. nobile in the treatment of inflamma-
tory disorders.113 Ps and EOs of Roman chamomile have been
also reported to possess in vivo antiinflammatory effects.110
C. nobile has been described to present cytotoxic effects
against several cancer cell lines. In the study of Guimarães
et al. (2013), the effects of methanolic extracts, infusions, and
decoctions in MCF-7, NCI-H460, HCT-15, HeLa, and HepG2
were evaluated. Methanolic extracts presented the best cyto-
toxic activity, with GI50 values ranging between 82.52 µg mL
−1
for MCF-7 and 168.40 µg mL−1 for HepG2. These results were
attributed to the high content of PC.106 Similarly, Kandelous
et al. (2016) investigated the anticancer as well as apoptotic
activity of ethyl acetate fraction of C. nobile on different cancer-
ous cell lines. The obtained results showed that the ethyl
acetate fraction of C. nobile exhibited antiproliferative activity
on MCF-7, K562, and human melanoma (SKMEL-3) cell lines,
causing cell apoptosis, while minimal growth inhibitory
response in normal cells.108
Regarding antimicrobial properties, several studies have
evaluated the extracts and compounds of C. nobile, both
in vitro and in vivo. The water extracts of Roman chamomile,
rich in PC, showed inhibitory activity against S. aureus, Bacillus
sp., P. aeruginosa, and E. coli, with inhibition zones ranging
between 12.66 and 10 mm.114 The EO of C. nobile have been
reported to present relatively low in vitro antifungal properties
against A. fumigatus, A. flavus, A. ochraceus, and Penicillium
citrinum.111 In another study, the authors investigated the anti-
microbial and wound healing properties of C. nobile against
P. aeruginosa in rats. An ointment was prepared with the etha-
nolic extract of Roman chamomile and applied in previously
infected wounds. The results showed that the C. nobile oint-
ment significantly inhibited P. aeruginosa and also stimulated
wound healing compared with the control.115
2.6. E. cannabinum
E. cannabinum, commonly known as hemp-agrimony, is a her-
baceous plant common in Europe, North America, Central
Asia, and Northern Africa. It has been used in traditional
medicine as a good choleretic, laxative, diuretic, and hypocho-
lesterolemic, as well as to treat skin diseases (e.g., psoriasis,
eczema, and boils), hepatitis, headache, diarrhea, diabetes
mellitus, and hypertension.116,117 The presence of F, Ps, non-
toxic alkaloids, SL, and EO is related to some biological pro-
perties, such as antioxidant, cytostatic, antibacterial, or
immunological properties.117–119 Pyrrolizidine alkaloids of
E. cannabinum comprise echinatine isomers, lycopsamine, and
intermedine, as well as a number of their beta-acetyl, beta-
angelyl/tiglyl, and beta-(iso)valeryl esters. From the alkaline
aqueous extract of E. cannabinum, polysaccharides were iso-
lated and identified as 4-O-methylglucuronoxylans. Finally, fla-
vones and flavonol glycosides were identified in the aerial
parts (AP) of E. cannabinum, comprising 6-methoxyflavones
hispidulin and eupafolin, flavonol glycosides astragalin,
kaempferol-3-rutinoside, hyperoxide, isoquercitin, and
rutin.120 This is a plant with a long history in traditional medi-
cine and some studies have been conducted to analyze its
properties.
Regarding the antioxidant properties, hydroalcoholic
extracts rich in PC such as caffeic acids and methoxylated fla-
vones—eupatorin and eupatilin B—showed a DPPH scaven-
ging activity of 59% at 3 mg mL−1.117 The antioxidant potential
of hemp-agrimony EO was assessed by the electrochemical
potential sweep technique, showing higher antioxidant activity
than quercetin.119 In the case of antiinflammatory activity,
more studies have been conducted. Ethanolic extracts modu-
lated the inflammatory signals of stimulated neutrophils, like
ROS, IL-8, production and release of TNF-α, and expression of
adhesion molecules. Eupatoriopicrin, the major SL found in
E. cannabinum, has shown inhibitory effects on the release of
IL-8 and TNF-α by activated human neutrophils.121 In mice
models subjected to LPS-induced damage, it has been
observed that the injection of E. cannabinum extracts reduced
the levels of proinflammatory cytokines TNF-α, IL-1β, and
IL-6.118 In thioglycolate-induced peritonitis mice models,
eupatoriopicrin suppressed the inflammatory response.121
E. cannabinum has been reported to have cytotoxic effects
against different cancer cell lines. For example, hydroalcoholic
extracts exerted a dose–response cytotoxic effect against leuke-
mia peripheral blood lymphocytes (Jurkat cells) at concen-
trations ranging between 7 and 500 μg mL−1.117 Ethanolic
extract also showed anticancer effects against the HT29 colon
cancer line, reducing cell viability and producing mitotic and
nuclear disruption and nonapoptotic cell death. In addition,
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the extract enhanced the effects of two compounds (bisphenol
A and doxorubicin) used as chemotherapeutic agents,
suggesting that E. cannabinum can be used as an adjuvant in
cancer treatment.122 Thymol derivatives, isolated from the R of
E. cannabinum, displayed cytotoxic effects against DLD-1,
human lymphoblastic leukemia cell line (CCRF-CEM), and
HL-60 cell lines.116 A recent study evaluated the antiprolifera-
tive effects of chloroform and water extracts of hemp-agrimony
against in vitro human mammary gland/breast carcinoma
(BT-20), HepG2, human colorectal adenocarcinoma (Caco-2),
and Jurkat cells. Chloroform extract was effective against all
the cell lines, with IC50 of 7.35 µg mL
−1 for Jurkat cells and
over 100 µg mL−1 for HepG2 and BT-20. In the case of water
extracts, only Jurkat cells were affected, with IC50 of 13.77 µg
mL−1. These results suggest that the active compounds may
have a nonpolar character.118
Regarding the antimicrobial properties, different
E. cannabinum extracts have shown inhibitory effects against
E. coli, B. cereus, S. aureus, E. faecalis, and C. albicans.123 EO
inhibited the growth of S. aureus, Streptococcus faecalis,
B. subtilis, B. cereus, P. mirabilis, E. coli, S. typhi, and
P. aeruginosa, but Gram-positive bacteria were found to be the
most sensitive.124 EO have also demonstrated antifungal
activity against fungi such as Botryodiplodia theobromae and
Colletotrichum gloeosporioides.125 Finally, the acetylcholinester-
ase inhibitory activity of n-hexane, ethyl acetate, and methanol
extracts of the Iranian E. cannabinum have been
investigated.126
2.7. H. stoechas
H. stoechas is the scientific name of an everlasting FL, which
grows in the Iberian Peninsula. Traditionally, an infusion of
FL and AP of this plant has been used to treat disorders such
as influenza and cold, fever, and nervousness, as well as a
diuretic and to treat gallbladder, urinary bladder, digestive,
and pancreatic problems.50,127,128 Regarding the chemical
composition, some compounds have been identified in this
plant, including F, chalcones, phloroglucinol derivatives, EO,
α-pyrones, and Te.129 Several biological studies have described
that H. stoechas possess antimicrobial, antiinflammatory, anti-
oxidant, anti-α-glucosidase, anti-tyrosinase, anti-acetylcholin-
esterase, and anti-dipeptidyl peptidase-4 properties.50,127
Among the reported bioactivities of H. stoechas, the anti-
oxidant property is the most analyzed. For example, methano-
lic extracts of H. stoechas FL and leafy stems were evaluated by
means of the total antioxidant capacity, DPPH and ABTS
radical scavenging assays, FRAP and chelating power, and inhi-
bition of β-carotene bleaching. The results showed that, in
general, the FL extracts had a higher antioxidant activity. It is
worth highlighting the fact that the correlation analysis
demonstrated a significant relationship between the results of
the antioxidant analysis with the PC present in the samples,
except the β-carotene bleaching assay.129 Another study ana-
lyzed the antioxidant activity of the hydroalcoholic extract and
decoction of H. stoechas and corroborated their antioxidant
properties by means of the DPPH scavenging, FRAP, inhibition
of β-carotene bleaching, and TBARS assays. Hydroalcoholic
extract showed a greater antioxidant activity in all the assays
(EC50 values between 79.84 and 36.62 μg mL−1) compared with
decoction due to the higher content of PC in the first prepa-
ration (135.61 mg g−1).128 Recently, different extraction tech-
niques were employed to extract H. stoechas and their anti-
oxidant activity was evaluated. Extracts obtained with acceler-
ated solvent extraction showed antioxidant effects in DPPH,
ABTS, FRAP, and cupric reducing antioxidant capacity
(CUPRAC) assays. As reported in other studies, these results
were correlated to the PC and F content, corroborating that
these compounds are involved in this bioactivity. However,
ultrasound-assisted extracts were the most active metal chela-
tor. In this case, the compounds involved are believed to be
thermolabile, which are degraded in other extractive tech-
niques, but not by ultrasonication-assisted extraction (UAE).50
Other biological activities have been attributed to this ever-
lasting plant. Extracts of H. stoechas have shown antimicrobial
effects against different bacteria and fungi. For example, etha-
nolic and water extracts of this everlasting plant displayed
inhibitory effects against E. coli, P. aeruginosa, P. mirabilis,
Klebsiella pneumoniae, Acinetobacter baumannii, E. faecalis,
S. aureus, C. albicans, and C. parapsilosis.130 Dichloromethane
extract of H. stoechas AP has also demonstrated antimicrobial
effects against S. aureus and Mycobacterium phlei as well as the
fungi C. albicans.50 Regarding antiinflammatory and antitumor
activities, fewer studies have been performed. It has been
described that H. stoechas presents potent antiinflammatory
effects via the inhibition of NF-κB and TNF-α.131 With regard
to antitumor activity, a methanolic extract of this plant inhibits
the proliferation of HeLa cells in vitro in a dose-dependent
manner.127 Finally, H. stoechas inhibited enzymes related to
the central nervous system and neurotransmitter metabolism,
such as acetylcholinesterase, monoamine oxidase, and tyrosi-
nase, suggesting that H. stoechas exhibits a neuroprotective
action.50,127
2.8. T. officinale
T. officinale is a herbaceous perennial flowering plant, native to
Eurasia and North and South Americas, although it is found
as a weed in all parts of the world.132 Traditionally, the FL, L,
and R of this plant have been used to treat digestive problems,
liver and gallbladder complaints, skin inflammation, and
arthritic and rheumatic diseases, as well as a diuretic, expec-
torant, and laxative.132–134 Among the selected plants of the
Asteraceae family, T. officinale is the most studied; numerous
authors have reported its biological activities, such as anti-
oxidant, antiinflammatory, antidiabetic, antimicrobial, and
anticancer activities, which have been related to several bio-
active compounds such as hydroxycinnamic acids (HA), F, cou-
marins, SL, and Ps.46,135
The antioxidant properties of T. officinale extracts and com-
pounds have been extensively studied, both in vitro and in vivo.
Some of the most recent ones will be explained below. For
example, different extracts have been demonstrated to sca-
venge several radicals, including DPPH, hydroxyl- and peroxyl-
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radical-induced intracellular oxidation, and suppressed lipid
oxidation. In particular, these effects were attributed to the
abundant presence of PC.46 Recently, the antioxidant effect of
different R fractions was evaluated by DPPH assay and also
assessing the effect on the oxidation markers on human
plasma. The HA-rich fractions showed the best results in
DPPH assays, but the fractions richer in SL and 4-hydroxyphe-
nylacetate inositol esters (PIEs) exhibited the greatest anti-
oxidant effect in plasma.133 Water and ethanol extracts of
T. officinale displayed antioxidant effects on RAW 264.7 cells by
inducing heme oxygenase-1, an antioxidant enzyme.136 Ps
extracted from dandelion R also show antioxidant properties,
which have been evaluated by radical scavenging assays
(DPPH, hydroxyl radical, and superoxide anion) and also in
hepatic L02 cells subjected to H2O2-induced damage. The
obtained results showed that Ps had the ability to scavenge all
the radicals in a dose-dependent manner. In the cell culture,
the Ps significantly reduced the toxicity associated with H2O2,
exerting a protective effect without any cytotoxic effect.134
Regarding in vivo studies, the oral administration of dandelion
formulations displayed antioxidant effects in obese rats,137
rabbits with a high-cholesterol diet, or alcohol-induced liver
damage in mice.46,138,139
Several studies have analyzed the antiinflammatory pro-
perties of this plant. Methanol and water extracts of dandelion
significantly reduced the inflammatory process caused by LPS
in RAW 264.7 cells; this was induced by inhibiting the acti-
vation of NF-κB, thereby preventing its translocation to the
nucleus. Subsequently, the expressions of iNOS and NO were
reduced, attenuating the inflammatory response. The authors
considered that these effects could be associated with the high
content of PC.140 More recently, L extracts suppressed inflam-
mation in cultured human colonic cells through the inhibition
of NF-κB activation and the consequent reduction in the tran-
scription of proinflammatory genes. Similar to the previous
study, PC are considered to play a fundamental role in antiin-
flammatory activities.141 In mice subjected to acetaminophen-
induced hepatotoxicity, the administration of PC from dande-
lion lead to a reduction in the serum levels of TNF-α and IL-1β
and the inhibition of iNOS and COX-2 expression.142 Ps also
have been reported to present antiinflammatory effects. In
CCl4-induced oxidative stress and inflammation-based rat
models, the administration of dandelion Ps suppressed the
activation of NF-κB and reduced the expression levels of proin-
flammatory factors such as iNOS, COX-2, TNF-α, and IL-1β.143
The proven antiinflammatory effects corroborate the tra-
ditional use of this plant to treat disorders such as arthritis,
rheumatism, and other inflammatory-related disorders.144,145
Numerous studies have demonstrated the anticancer prop-
erty. An aqueous extract of dandelion R has been shown to
induce apoptosis in colon cancer cells, but not in normal cells.
In addition, the extract inhibited the migration and invasion
of cancer cells in a scratch wound healing assay, suggesting
anti-metastasis activity. The effect of T. officinale extract was
also evaluated in xenograft mice. The obtained results demon-
strated that the oral intake of the extract retarded the growth
of cancerous cells.146 R methanolic extracts of dandelion
reduced—in a dose-dependent manner—the viability and trig-
gered the apoptosis of HepG2, MCF7, and human colon
HCT116 cancer cell lines.147 A recent study demonstrated that
dandelion Ps inhibited the proliferation of hepatocellular car-
cinoma cell in vitro, inducing cell apoptosis and cell-lifecycle
arrest.148
T. officinale has shown antimicrobial properties against
different bacteria such as S. aureus, E. coli, K. pneumonia,
P. mirabilis, Micrococcus luteus, Vibrio cholera, P. aeruginosa,
B. cereus, and Shigella sonnei, as well as fungi species such as
C. albicans, C. neoformans, A. niger, and B. cinerea.135,149 This
plant also presents antiviral effects against influenza and
hepatitis C viruses by the inhibition of replication.150,151
Finally, other properties have been attributed to T. officinale,
such as anticoagulant,133,152 α-glucosidase inhibitory activity,153
immunostimulant,46 and neuroprotective activity.154
3. Current applications of TP from
Asteraceae family
As shown in the previous sections, different studies have been
developed to disclose the chemical profile of many TP and
relate their composition and biological properties with their
potential applications. Few representatives of the Asteraceae
family have been used as natural ingredients in pharmacologi-
cal, medicinal, and cosmetic products, and they have also
been found in food products. In fact, some of these species are
sold in different formats, such as teas, capsules, powders, etc.,
which are considered to be “primary shelf-care products”. The
multiple properties of the compounds present in some of
these plants have prompted the development of patents, as
listed in Table 3. Some of the patents shown in the table relate
to products that are orally administered, suggesting that the
extracts and compounds of the selected plants could be used
for the development of functional foods.
A. millefolium has been tested in clinical trials with
different target diseases or affections but with inflammation
processes associated as the common point. A. millefolium was
demonstrated to ameliorate pain symptoms after episiotomies
or during dysmenorrhea periods; further, it reduced the sever-
ity of oral mucositis and decreased biomarkers or scores/
ascites when applied for chronic kidney disease or cirrhosis,
respectively.55 In a vulvovaginal candidiasis clinical trial, the
results were not conclusive. Even though the vulvar erythema
improved after the application of A. millefolium, the culture
was still positive in nearly 50% subjects.155 In 2011, the
European Medicines Agency (EMA) published the final
adopted community herbal monograph on A. millefolium. In
this report, the therapeutic indications included the treatment
of symptoms of some diseases or affections evaluated through
the abovementioned clinical trials. The EMA indicated the use
of A. millefolium as a temporary treatment for the loss of appe-
tite; for mild, spasmodic gastrointestinal complaints (bloating
and flatulence); minor spasm associated with menstrual
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Table 3 Asteraceae-based current applications. Different species belonging to the Asteraceae family have been used for obtaining extracts from
different plant parts in order include them as a part of different topical products that permit the exploitation of their properties and creating innova-
tive applications and patented them
Species
Plant
parts Properties Application Patent no.
A. millefolium FL Antiseptic and anti-inflammatory Treatment of oily hair LU85863A1, US4948583A,
CA1269937A
AP Malassezia yeast inhibitor Dandruff DE3300491A1, FR2993455B1,
US20150086498A1,
WO2013160066A1
AP — Deodorant and antiperspirant US20150086498A1,
WO2013160066A1
Any Anti-metastatic Treatment and/or prevention of
neoplastic disorders
WO2001013929A1
A. montana — Antiseptic, lubricating and
vasoconstrictive
Ocular improvement of the vascular
permeability, histamine modulation and
inflammatory reduction
MX2017001879A
— Anti-inflammatory, analgesic and
antimicrobial
Treatment of spinal cross-sectional
syndrome
DE202007013655U1
FL Anti-inflammatory and analgesic Treatment of contusions by long-acting
slow-release
CN105412191A
FL/R Anti-inflammatory Acne dispelling and skin-care CN106214538A
FL Analgesic Pain relief US20200163910A1
— Vasodilatator Treatment of shingles US20160106797A1
FL Plumping Temporal lip volume increase US20200170925A1
— — Bruises heal, analgesic, anti-
inflammatory
US20180050076A1
— — Wound healing and its prevention post-
surgery, post-laser or post-traumatic
bruising
WO2009055433A1
B. perennis Any Lightening Treatment of undesired skin
pigmentation
AU2008364312B2
FL/L Lightening Dermatosis with cutaneous pigmentation CN101917965B
FL Antioxidant, anti-inflammatory,
and lightening
Treatment of hyperpigmentation CA2550863C
FL Neuroprotective Treatment of hypoxia, especially that
caused by ischemia
DE4206233C1
L Nutritional Detoxification, diuresis, reduction of





Improve cat litter properties (density,
hygroscopicity, bacterial repealing and
fragrance)
CN106069818A
C. officinalis FL Antioxidant, anti-inflammatory,
antibacterial, and healing
Treatment of cutaneous manifestations
due to epigenomic imbalance in skin
cells
US20160074455A1
Any Anti-inflammatory and dermis
cells hyperproliferation
Treatment of psoriasis US6225342B1,
WO1998032761A1
— Anti-inflammatory Pain alleviation, calming nerves,
endocrine adjustment, digestion
promotion, treat dermal treatment
CN106619363A
— Moisturizing Skin moistening, moisturizing, calming
and improving sensitive skin
CN103520038A
— Epithelizing, bactericidal and
bacteriostatic
Treatment of postoperative, post-
traumatic wounds, grade I to III A burns,
diaper irritations of newborns and
infants, and ladders
RO128266B1
FL/L Anti-inflammatory, flavoring and
preserving
Prevention of gingival disorder KR20110067358A
FL Anti-anaphylaxis and moisture
retention water
Relieving and allergy-preventing CN105581940A
FL Anti-proteolytic and cell growth
inhibition
Inhibition of skin inflammation and
normalization of cell disorders
US20140295004A1
C. nobile — Antioxidant Food preservation CN102638993B,
WO2011045757A1
FL Aromatic Increasing aroma richness, sweet rhyme





Maintenance or increment of
stem cells pigmentation
Preventive agent for canities apparition JP2012025736A
FL Antioxidant, anti-inflammatory,
and immunostimulant





Taste improver Taste and aftertaste improvement for
high sweetness sweetener
JP2018191582A
Food & Function Review

























































parts Properties Application Patent no.
E. cannabium — Dyer Natural and environmental-friendly dye




Veterinary treatment of respiratory
diseases such as cough, phlegm,
influenza, or bronchitis
CN102048785B
— Antiparasitic Treatment of chicken coccidiosis CN104758516A
— Antibiotic or antiviral Bacteria or virus inhibitor for medical
use or feed additive
CN101422481A
— Deodorant and antibiotic Deodorant CN101947327B
H. stoechas AP/FL Periostin synthesis Regeneration of cutaneous tissues and
skin anti-aging
FR3040625A1
— Collagen and periostin synthesis Stimulation of vaginal collagen
generation and periostin reparation for
wrinkle resistance
CN106038385A








R Dietotherapeutic Honey-processed dandelion instant coffee CN101766248A
L Antioxidant Functional food: chocolate with
antioxidant properties
KR101032937B1
FL/P/R Jelly matrix Functional food: jellying agent that
improve nutritional/functional properties
of bread, biscuits, cakes, etc.
KR101445678B1
R Anti-inflammatory and detoxifying Dandelion juice with black garlic for
preventing colds and other diseases
KR20100028190A
— Hepatoprotective Mixture of fermented dandelion and
thistles for improving hepatic functions
and protect hepatocytes
KR20140093437A





Prevention or improvement of male
climacteric
US20150335694A1
R Latex rubber matrix Extraction of latex rubber to apply to
rubber, sugar syrups, soluble fiber, food,
or beverages
US9611363B2
A. millefolium + A. montana — Anti-inflammatory Cosmetic or dermatological treatment of
the skin, hair, mucosa
US20040170670A1
A. montana + C. officinalis FL Analgesic Relief of painful skin ailments US20170071874A1
A. montana + C. officinalis FL Emollient Reduction of cellulite or fat build-ups US4795638A
A. montana + C. officinalis — Anti-viral Treatment against Herpes simplex virus US20200230187A1
A. millefolium +
C. officinalis + T. officinale
— Anti-inflammatory, and healing Treatment of psoriasis US5165932A
A. millefolium + A. montana
+ C. officinalis
FL Anti-inflammatory Treatment of inflammation, pain, or
swelling
US20170056465A1
A. millefolium + B. perennis
+ C. officinalis + C. nobile +
elichrysum sp. +
T. officinale
— — Extracellular protease inhibitors US20040175439A1
A. millefolium + A. montana
+ B. perennis +
C. officinalis+
Any Astringent, anti-inflammatory,
antiseptic, cicatrizer, tonic, and
emollient
Skin treatment US4933177A
A. millefolium + A. montana
+ B. perennis + C. officinalis
R/FL Anti-inflammatory Treatment of musculoskeletal
inflammations (arthrosis, osteoarthritis,
rheum, joint stiffness, etc.)
US9687518B2
A. montana + C. officinalis FL Skin-protecting, regenerating,
anti-inflammatory and
antimicrobial
Treatment of hard-healing wounds DE202006010673U1
C. officinalis + Cannabis
sativa
FL Anti-inflammatory Reduction of skin lesions (atopic
dermatitis, urticaria, radiotherapy or UV-
burn, acne)
WO2017175126A1




Treatment of dermatosis using low-
molecular peptides and free amino acids
WO2005063266A1,
EP1708725A1
C. offininalis + T. officinale
+ Euphrasia officinalis
— Anti-inflammatory Eye-drops, eye-rising solution for treating
tired or dry eyes, conjunctivitis or
blepharitis
HRP20120273A2
Abbreviations: AP, aerial parts; R, roots; FL, flowers; L, leaves.
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periods; or as a healing agent for small superficial wounds.
The established posology depends on the administration and
the type of extract. Gastrointestinal affections can be treated
with different herbal preparations to consume orally: infusion
(2–4 g in 250 mL of boiling water, 3–4 times per day),
expressed juice (5–10 mL, 2–3 times per day), liquid extract
(2–4 mL, 3 times per day), and tincture (ethanol 45% 2–4 mL,
3 times per day or ethanol 31.5% 4.3 mL, 4 times per day). For
menstruation pain, the EMA suggested the preparation of a
herbal tea (1–2 g in 250 mL boiling water, 2–3 times per
day).156
A study based on 443 patients analyzed the potential of
A. montana for causing allergic reactions. The obtained results
showed that A. montana produces very scarce contact sensitiz-
ation processes quantified with a total percentage of 1% (5
patients) and mostly associated with the presence of nickel.157
In fact, the EMA considers the therapeutic use of A. montana to
be safe for adolescents, adults, and elderly people for the fol-
lowing dosages: 20–25% using tincture or 50% liquid extract
in a base for creating a semisolid presentation that can be
applied as a thin layer on the affected area up to a maximum
of three or four times per day, respectively; and 2.5 mL as an
impregnated dressing liquid for its application on the affected
area, three to four times daily. Therapeutic indications pro-
vided by the EMA for A. montana include its application for the
relief of bruises, sprains, and localized muscular pain.158
However, in the literature, many alternatives for A. montana
applications have been suggested. Fresh A. montana plant gel
(100 g containing 50 g fresh plant tincture extracted at a ratio
of 1 : 20) administrated twice a day for a month and a half was
useful for the treatment of mild-to-moderate knee osteoar-
thritis. This treatment showed a reduction in the Western
Ontario and McMaster Universities Osteoarthritis Index, with
lower score for pain and stiffness and more than 75% patients
would apply it again.159 This is just one example of the mul-
tiple clinical studies that have been developed to reveal the
alternative applications of A. montana. These works utilized
A. montana for the potential treatment of very different dis-
eases such as stroke, venous insufficiency, post-surgery treat-
ments, articulation diseases or pain, muscle soreness, dental
issues, etc.79 The results demonstrated very variable data due
to the different approaches of each work. Different A. montana
concentrations, extracts, and presentations were used to treat
diverse kinds of diseases or pains; the number of subjects
varied from one study to another. This variability in the experi-
mental conditions hinders a comparison of the obtained
results.
To our knowledge, the human use of B. perennis has not
been reported by the EMA so far. However, as stated before,
different studies have demonstrated its efficacy as antiinflam-
matory and anti-arthritic90,91 and antidiabetic and anti-
obesity90,160 agents, hematoprotective and nephroprotective161
agents, and promoter of collagen synthesis.49
The EMA indicates the use of C. officinalis for the sympto-
matic treatment of minor skin inflammations (sunburn) or
minor wounds but also for treating mouth or throat inflam-
mations. The dosage for skin treatment in children, adoles-
cents, adults, and elderly includes infusions for impregnated
dressings prepared with 1–2 g in 150 mL warm water or in
boiled water but diluted at the 1 : 3 ratio (2–4 times per day), as
well as for semisolid dosage, it should contain from 2 to 20%
of C. officinalis extract, which can be administrated as a thin
layer to the affected area (2–4 times per day). For treating
minor inflammations in adolescents, adults, and elderly, it
can be used as an infusion (1–2 g per 150 mL water) or a 2%
solution for rinsing or gargling 2–4 times per day.158 As an
example for throat treatment, a study used C. officinalis
together with two other plants to treat gingivitis from a
mouthwash that contained hydroalcoholic extracts (5% v/p) of
these plants resulting in an effective treatment.162
Similar to A. montana, C. officinalis was demonstrated to
rarely provoke allergic reactions (in only 2% cases) that were
also related with the presence of nickel. Hence, most clinical
trials performed with C. officinalis have focused on the treat-
ment of skin affections such as burns, dermatitis, wounds,
ulcers, or episiotomies. In all these clinical trials, the appli-
cation of C. officinalis was demonstrated to be safe and
resulted in an improvement in the healing capacity of medical
treatment when used as a co-adjuvant or even equalize the
healing capacity of the medical treatment when used in com-
parative studies.163,164 Additionally, C. officinalis has been
tested for the treatment of other diseases, for instance, as an
alternative to the use of clotrimazole for treating vaginal candi-
diasis or as a cost-effective treatment for tobacco-induced leu-
koplakia, instead of lycopene. For candidiasis, C. officinalis
acts more slowly than clotrimazole but it had a long-term
effect.165 For leukoplakia, C. officinalis showed an equivalent
efficacy as that of lycopene.166 However, as it happens in clini-
cal trials performed with other TP, the experimental design
and outcome measures are very variable between different
studies; therefore, well-designed and validated protocols are
required to determine the efficacy of calendula.163
The EMA considers the use of C. nobile as a therapeutic for
mild, spasmodic gastrointestinal complaints (bloating and
flatulence) or for treating minor mouth or throat inflam-
mations. The posology for these affections are—for oral use—
1–4 g as an infusion or 1–4 mL of liquid extract thrice per day
and for oromucosal use as an infusion with 2–3 g applied 3–4
per day to wash the mouth or throat.167 C. nobile clinical trials
are scarce since most of them named after chamomile have
been developed with Matricaria chamomilla. Among the avail-
able studies in the literature, two randomized double–blind
studies have suggested that the application of 2% C. nobile gel
stabilizes or even improves the symptoms caused by the oral
lichen planus disease.168,169 However, the administration of
the same gel for treating the burning mouth syndrome does
not appear to have a positive effect.170 Other works have evalu-
ated the cosmetic potential capacity of C. nobile. This cosmetic
application includes the oral administration of C. nobile,
Crataegus laevigata, Houttuynia cordata, and Vitis vinifera. A
12-week treatment was able to suppress yellow and brown
spots on the skin.171
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For E. cannabinum and H. stoechas, no EMA report or clini-
cal trials for its single administration were found in the scien-
tific literature. E. cannabinum was described to be contained in
a commercial cream together with other natural components
(coconut oil, palm oil, castor oil, olive oil, beeswax, wheat oil,
and canola seed oil) and to be effective for minimizing post-
burn itch.172 Similarly, H. stoechas was one of the extracts used
as an ingredient of syrup based on acacia honey and on moi-
eties derived from Malva sylvestris, Inula helenium, and
Plantago major extracts. A clinical trial using this syrup was
performed in a subject population of 106 children with persist-
ent cough. The administration of the syrup reduced the sever-
ity and shortened the cough duration (preprint work).173
The therapeutic use of T. officinale reported by the EMA
includes its application for relieving mild digestive disorders
(abdominal fullness, flatulence, and slow digestion) and even
for temporary loss of appetite. It is also considered to be a
diuretic and acts as an adjuvant in minor urinary complaints.
For digestive affections, it can be consumed as a decoction
(3–4 g), as an infusion (4–10 g), as a dry extract (150 mg), as a
liquid extract (1–3.31 g equivalents), or as a fresh juice
(10 mL), with a frequency of 3 times per day. For urinary dis-
orders, it can be ingested as a decoction or infusion, similar to
that in digestive cases.174 Clinical trials for T. officinale are also
scarce for single-plant administration. In a study with a small
population (17 subjects), a hydroethanolic extract of
T. officinale fresh leaves was administrated. The urinary
volume and frequency were determined before and after
T. officinale administration. Both volume and frequency were
increased with the treatment, which suggested its diuretic
capacity.175 Another work evaluated the efficacy of doing
gargles with a T. officinale extract for improving the oral
hygiene status of 11 subjects with orthodontic appliances. The
orthodontic plaque index and the salivary S. mutans count
were determined three weeks after the collocation of the ortho-
dontic appliances. Both parameters were decreased after one
week of treatment, suggesting that T. officinale may be incor-
porated as a natural ingredient for the development of innova-
tive mouthwashes and other dental supplies aimed to preserve
oral hygiene.176 Other clinical trials involve a complex of
herbal extracts apart from T. officinale, as in the case of a com-
mercial cream that has been described to contain extracts of
Achilleae herba, Allium sativum, Calendulae flos, Urtica folium,
and Veronica officinalis herbs. This cream was evaluated in 19
patients from a total of 42 subjects for 12 weeks. Some treated
patients reported positive clinical response in the treatment of
psoriatic scalp lesions; in all of them, the symptoms were less
severe than those in the placebo group.177
Many published works have investigated the use of homeo-
pathic concentrations of herbal extracts, which hinder their
real effect when compared with a placebo or other chemical
compounds. Besides, the use of TP has an inherent variability
due to the geographical distribution, the collection season, the
plant part used for the extraction protocol, the extraction pro-
tocol itself, the final concentration applied, etc. Thus, to
obtain comparable results, a chemical profile identification
should be performed, major biomolecules involved in the
mechanism of action disclosed, and their concentration and
administration to be specified. Therefore, more scientific
works must be developed to determine the actual application
of TP-based extracts or molecules.
4. Conclusions and perspectives
In the last few years, a growing interest in the bioactivities and
compounds from TP has been observed, both to preserve tra-
ditional knowledge and to recover bioactive compounds for
industrial applications, including the food industry. In fact,
numerous scientific studies have evaluated the action mecha-
nisms behind their beneficial properties in health, justifying
its use in traditional medicine. Considering the scientific
works compiled in this study, they confirm that the eight
selected plants of the Asteraceae family present health benefits
and their bioactivities and chemical composition are related to
the current patents in which they are applied. In addition,
these plants contain diverse bioactive compounds, particularly
PC, Eos, and SL, whose recovery could be of interest for the
development of new applications in the food industry, such as
enrichment of the food matrix to enhance their beneficial pro-
perties and also the substitution of synthetic antioxidants,
antimicrobials, or colorants. To favor its application in the
food industry, more studies and clinical trials are still needed,
particularly in the case of B. perennis, C. nobile, E. cannabinum,
and H. stoechas, so that the knowledge gap between the tra-
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ORAC Oxygen radical absorbance capacity





A-549 Human lung carcinoma
BT-20 Human mammary gland/breast carcinoma
Caco-2 Heterogeneous human epithelial color-
ectal adenocarcinoma
CCRF-CEM Human lymphoblastic leukemia cell line
DLD-1 Human colon adenocarcinoma




HL-60 Human promyelocytic leukemia
HT29 Human colon cancer
K562 Human erythroleukemia
MCF-7 Breast adenocarcinoma
MiaPaca-2 Pancreatic human tumor
MRC-5 Human fetal lung






IL-1β Interleukin 1 beta
IL-6 Interleukin 6
iNOS Inducible nitric oxide synthase
LPS Lipopolysaccharide
NAG-1 Nonsteroidal antiinflammatory drugs-
activated gene-1
NF-κB Nuclear factor kappa-light-chain enhan-
cer of activated B cells
NO Nitric oxide
PPARs Peroxisome proliferator-activated receptors
ROS Reactive oxygen species
TNF-α Tumor necrosis factor alpha
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